Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy.

MLA

Young, Christopher C., et al. “Clopidogrel Hyper-Response Increases Peripheral Hemorrhagic Complications without Increasing Intracranial Complications in Endovascular Aneurysm Treatments Requiring Dual Antiplatelet Therapy.” Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, vol. 105, Nov. 2022, pp. 66–72. EBSCOhost, https://doi.org/10.1016/j.jocn.2022.09.005.

APA

Young, C. C., Bass, D. I., Cruz, M. J., Carroll, K., Vanent, K. N., Lee, C., Sen, R. D., Feroze, A. H., Williams, J. R., Levy, S., McCray, D., Kelly, C. M., Barber, J., Kim, L. J., & Levitt, M. R. (2022). Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 105, 66–72. https://doi.org/10.1016/j.jocn.2022.09.005

Chicago

Young, Christopher C, David I Bass, Michael J Cruz, Kate Carroll, Kevin N Vanent, Chungeun Lee, Rajeev D Sen, et al. 2022. “Clopidogrel Hyper-Response Increases Peripheral Hemorrhagic Complications without Increasing Intracranial Complications in Endovascular Aneurysm Treatments Requiring Dual Antiplatelet Therapy.” Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia 105 (November): 66–72. doi:10.1016/j.jocn.2022.09.005.